Manufacturing Process Development of Tegoprazan as a Potassium-Competitive Acid Blocker (P-CAB)

已完结 15 由大魔王发布于 2025/10/17 9:48:08

DOI:10.1021/acs.oprd.4c00005
作者：Jae-Hong Kweon Jae-Hong Kweon School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea Process Development Center, HK inno.N Corporation, Icheon 17389, Republic of Korea More by Jae
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1021/acs.oprd.4c00005
备注：谢谢！急用@@

American Chemical Society (ACS)

Abstract：Tegoprazan, a selective potassium-competitive acid blocker, was approved in 2018 in the Republic of Korea for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis (EE

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyEnhanced Photocatalytic Oxygen Evolution Using Copper-Coordinated Perylene Diimide Nanorod Assemblies